Abstract The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic
Shock 2020 (J-SSCG 2020), a Japanese-specific set of clinical practice guidelines for sepsis …

Background The objective of this study was to systematically evaluate the clinical value of
procalcitonin and C‐reactive protein in the diagnosis of adult patients with sepsis. Method …

Pneumonia is the leading infectious cause of mortality worldwide and one of the most
common lower respiratory tract infections that is contributing significantly to the burden of …

Background Early and accurate diagnosis of sepsis is challenging. Although procalcitonin
and presepsin have been identified as potential biomarkers to differentiate between sepsis …

Rationale: Sepsis is the leading cause of death in adult ICUs. At present, sepsis diagnosis
relies on nonspecific clinical features. It could transform clinical care to have immune-cell …

Sepsis was recently redefined as a life-threatening disease involving organ dysfunction
caused by a dysregulated host response to infection. Biomarkers play an important role in …

Sepsis is a serious medical condition that occurs in 30% of patients in intensive care units
(ICUs). Early detection of sepsis is key to prevent its progression to severe sepsis and septic …

Abstract Sepsis, which kills over 200,000 patients and costs over $20 billion in the United
States alone, presents a constant but preventable challenge in the healthcare system …

Background Lactate/albumin (LA/ALB) and procalcitonin/albumin (PCT/ALB) ratios have
been implicated in predicting mortality in sepsis patients. However, their prognostic value …

Background: Sepsis is the leading cause of death in children worldwide. Early recognition
and treatment are essential for preventing progression to lethal outcomes. CRP and …